5EM7 | pdb_00005em7

EGFR kinase domain mutant "TMLR" with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxidanylidene-1~{H}-pyridine-3-carboxamide


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.81 Å
  • R-Value Free: 
    0.216 (Depositor), 0.227 (DCC) 
  • R-Value Work: 
    0.189 (Depositor), 0.201 (DCC) 
  • R-Value Observed: 
    0.190 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 5EM7

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Pyridones as Highly Selective, Noncovalent Inhibitors of T790M Double Mutants of EGFR.

Bryan, M.C.Burdick, D.J.Chan, B.K.Chen, Y.Clausen, S.Dotson, J.Eigenbrot, C.Elliott, R.Hanan, E.J.Heald, R.Jackson, P.La, H.Lainchbury, M.Malek, S.Mann, S.E.Purkey, H.E.Schaefer, G.Schmidt, S.Seward, E.Sideris, S.Wang, S.Yen, I.Yu, C.Heffron, T.P.

(2016) ACS Med Chem Lett 7: 100-104

  • DOI: https://doi.org/10.1021/acsmedchemlett.5b00428
  • Primary Citation Related Structures: 
    5EM5, 5EM6, 5EM7, 5EM8

  • PubMed Abstract: 

    The rapid advancement of a series of noncovalent inhibitors of T790M mutants of EGFR is discussed. The optimization of pyridone 1, a nonselective high-throughput screening hit, to potent molecules with high levels of selectivity over wtEGFR and the broader kinome is described herein.


  • Organizational Affiliation
    • Genentech , South San Francisco, California 94080, United States.

Macromolecule Content 

  • Total Structure Weight: 38.08 kDa 
  • Atom Count: 2,474 
  • Modeled Residue Count: 300 
  • Deposited Residue Count: 331 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Epidermal growth factor receptor331Homo sapiensMutation(s): 5 
Gene Names: EGFRERBBERBB1HER1
EC: 2.7.10.1
UniProt & NIH Common Fund Data Resources
Find proteins for P00533 (Homo sapiens)
Explore P00533 
Go to UniProtKB:  P00533
PHAROS:  P00533
GTEx:  ENSG00000146648 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00533
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
5Q4

Query on 5Q4



Download:Ideal Coordinates CCD File
C [auth A]4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperazin-1-yl)phenyl]-2-oxidanylidene-1~{H}-pyridine-3-carboxamide
C24 H27 N5 O3
DWKPGVACBGLMCU-UHFFFAOYSA-N
SO4

Query on SO4



Download:Ideal Coordinates CCD File
B [auth A]SULFATE ION
O4 S
QAOWNCQODCNURD-UHFFFAOYSA-L

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.81 Å
  • R-Value Free:  0.216 (Depositor), 0.227 (DCC) 
  • R-Value Work:  0.189 (Depositor), 0.201 (DCC) 
  • R-Value Observed: 0.190 (Depositor) 
Space Group: I 2 3
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 146.105α = 90
b = 146.105β = 90
c = 146.105γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2015-12-30
    Type: Initial release
  • Version 1.1: 2016-02-10
    Changes: Database references
  • Version 1.2: 2024-03-06
    Changes: Data collection, Database references, Derived calculations